Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthroplasty, Replacement, Knee | 138 | 2024 | 1458 | 23.720 |
Why?
|
Arthroplasty, Replacement, Hip | 111 | 2024 | 1462 | 16.720 |
Why?
|
Prosthesis-Related Infections | 68 | 2024 | 538 | 15.270 |
Why?
|
Knee Prosthesis | 31 | 2023 | 425 | 7.540 |
Why?
|
Arthroplasty, Replacement | 25 | 2021 | 339 | 6.670 |
Why?
|
Arthritis, Infectious | 28 | 2023 | 367 | 6.550 |
Why?
|
Surgical Wound Infection | 32 | 2024 | 1540 | 4.990 |
Why?
|
Knee Joint | 49 | 2024 | 1680 | 4.710 |
Why?
|
Osteoarthritis, Knee | 23 | 2024 | 1222 | 4.660 |
Why?
|
Orthopedics | 26 | 2023 | 904 | 4.640 |
Why?
|
Hip Prosthesis | 26 | 2023 | 917 | 4.410 |
Why?
|
Orthopedic Procedures | 24 | 2022 | 1288 | 3.800 |
Why?
|
Reoperation | 61 | 2024 | 4201 | 3.080 |
Why?
|
Arthroplasty | 14 | 2023 | 305 | 2.910 |
Why?
|
Joint Diseases | 9 | 2022 | 480 | 2.680 |
Why?
|
Hip Fractures | 7 | 2022 | 955 | 2.560 |
Why?
|
Staphylococcal Infections | 14 | 2023 | 1400 | 2.560 |
Why?
|
Fractures, Spontaneous | 4 | 2020 | 230 | 2.520 |
Why?
|
Femoral Neck Fractures | 4 | 2023 | 138 | 2.330 |
Why?
|
Anti-Bacterial Agents | 30 | 2024 | 7181 | 2.310 |
Why?
|
Anesthesia, Spinal | 4 | 2022 | 269 | 2.140 |
Why?
|
Antibiotic Prophylaxis | 7 | 2020 | 639 | 1.940 |
Why?
|
Postoperative Complications | 32 | 2023 | 15295 | 1.890 |
Why?
|
Retrospective Studies | 131 | 2024 | 77449 | 1.790 |
Why?
|
Bone Cements | 7 | 2023 | 325 | 1.770 |
Why?
|
Physicians, Women | 6 | 2022 | 486 | 1.750 |
Why?
|
Osteoarthritis, Hip | 6 | 2023 | 412 | 1.700 |
Why?
|
Musculoskeletal Diseases | 6 | 2022 | 581 | 1.620 |
Why?
|
Prosthesis Design | 18 | 2023 | 2110 | 1.560 |
Why?
|
Femoral Fractures | 8 | 2023 | 376 | 1.550 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 8 | 2023 | 687 | 1.490 |
Why?
|
Biofilms | 8 | 2024 | 617 | 1.460 |
Why?
|
Femur | 12 | 2024 | 1297 | 1.410 |
Why?
|
Prosthesis Failure | 18 | 2023 | 1206 | 1.400 |
Why?
|
Humans | 319 | 2024 | 744343 | 1.400 |
Why?
|
Authorship | 3 | 2022 | 271 | 1.380 |
Why?
|
Hyaluronic Acid | 4 | 2021 | 491 | 1.340 |
Why?
|
Mepivacaine | 3 | 2022 | 10 | 1.310 |
Why?
|
Periprosthetic Fractures | 7 | 2023 | 62 | 1.300 |
Why?
|
Hospitals, Special | 3 | 2017 | 101 | 1.290 |
Why?
|
Range of Motion, Articular | 13 | 2022 | 1578 | 1.280 |
Why?
|
Osteoarthritis | 6 | 2024 | 1036 | 1.270 |
Why?
|
Fracture Fixation | 2 | 2021 | 354 | 1.260 |
Why?
|
Personnel Selection | 2 | 2020 | 189 | 1.250 |
Why?
|
Synovial Fluid | 10 | 2022 | 394 | 1.250 |
Why?
|
Vancomycin | 5 | 2019 | 501 | 1.230 |
Why?
|
Joint Prosthesis | 5 | 2017 | 258 | 1.190 |
Why?
|
Myositis | 2 | 2021 | 251 | 1.180 |
Why?
|
Osteomyelitis | 2 | 2021 | 402 | 1.140 |
Why?
|
Cefazolin | 2 | 2016 | 96 | 1.090 |
Why?
|
Dwarfism | 2 | 2017 | 146 | 1.090 |
Why?
|
Operating Rooms | 6 | 2023 | 817 | 1.090 |
Why?
|
Aged | 113 | 2023 | 163280 | 1.080 |
Why?
|
Chromium Alloys | 4 | 2018 | 77 | 0.970 |
Why?
|
Debridement | 6 | 2024 | 492 | 0.950 |
Why?
|
Middle Aged | 111 | 2022 | 213383 | 0.950 |
Why?
|
Male | 136 | 2024 | 350118 | 0.930 |
Why?
|
Injections, Intra-Articular | 6 | 2021 | 278 | 0.910 |
Why?
|
Female | 137 | 2024 | 380194 | 0.890 |
Why?
|
Treatment Outcome | 56 | 2024 | 63114 | 0.880 |
Why?
|
Arthritis, Rheumatoid | 9 | 2024 | 3712 | 0.860 |
Why?
|
Tranexamic Acid | 3 | 2021 | 146 | 0.860 |
Why?
|
Cross Infection | 4 | 2019 | 1416 | 0.850 |
Why?
|
Postoperative Period | 13 | 2022 | 1842 | 0.840 |
Why?
|
Hip Joint | 6 | 2022 | 1002 | 0.840 |
Why?
|
Bone Diseases, Infectious | 2 | 2019 | 18 | 0.820 |
Why?
|
Aged, 80 and over | 47 | 2023 | 57776 | 0.800 |
Why?
|
Viscosupplements | 1 | 2020 | 23 | 0.760 |
Why?
|
Humeral Fractures | 2 | 2020 | 272 | 0.740 |
Why?
|
Healthcare Disparities | 6 | 2022 | 3158 | 0.730 |
Why?
|
Hyperglycemia | 5 | 2021 | 1373 | 0.730 |
Why?
|
Arthralgia | 3 | 2021 | 456 | 0.720 |
Why?
|
Anesthesia | 2 | 2022 | 1561 | 0.720 |
Why?
|
Pain, Postoperative | 8 | 2023 | 1643 | 0.720 |
Why?
|
Infection Control | 5 | 2020 | 966 | 0.720 |
Why?
|
Fellowships and Scholarships | 4 | 2023 | 1076 | 0.720 |
Why?
|
United States | 52 | 2023 | 69872 | 0.710 |
Why?
|
Therapeutic Irrigation | 3 | 2021 | 301 | 0.710 |
Why?
|
Shoulder Fractures | 1 | 2020 | 88 | 0.710 |
Why?
|
Women, Working | 1 | 2020 | 87 | 0.690 |
Why?
|
Joints | 2 | 2018 | 326 | 0.690 |
Why?
|
Community-Acquired Infections | 2 | 2013 | 465 | 0.680 |
Why?
|
School Admission Criteria | 1 | 2020 | 105 | 0.660 |
Why?
|
Emotional Intelligence | 1 | 2020 | 136 | 0.660 |
Why?
|
Fracture Fixation, Internal | 6 | 2020 | 917 | 0.660 |
Why?
|
Collagen Diseases | 1 | 2018 | 34 | 0.650 |
Why?
|
Tibia | 9 | 2024 | 1077 | 0.640 |
Why?
|
Medicare | 13 | 2023 | 6566 | 0.630 |
Why?
|
Rheumatology | 6 | 2022 | 576 | 0.630 |
Why?
|
alpha-Defensins | 1 | 2017 | 28 | 0.630 |
Why?
|
Personality Assessment | 1 | 2020 | 647 | 0.630 |
Why?
|
Length of Stay | 8 | 2023 | 6309 | 0.620 |
Why?
|
Remote Consultation | 1 | 2020 | 238 | 0.620 |
Why?
|
Patient Dropouts | 1 | 2020 | 421 | 0.620 |
Why?
|
Hospitals, Group Practice | 1 | 2017 | 4 | 0.610 |
Why?
|
Contracture | 2 | 2018 | 223 | 0.610 |
Why?
|
Risk Factors | 41 | 2023 | 72290 | 0.600 |
Why?
|
Education, Distance | 1 | 2021 | 251 | 0.580 |
Why?
|
Prospective Studies | 33 | 2023 | 53288 | 0.580 |
Why?
|
Acute Kidney Injury | 3 | 2019 | 1972 | 0.570 |
Why?
|
Recovery of Function | 7 | 2021 | 2925 | 0.560 |
Why?
|
Radiography | 12 | 2023 | 7023 | 0.560 |
Why?
|
Staphylococcus aureus | 10 | 2023 | 1451 | 0.560 |
Why?
|
Diabetes Complications | 3 | 2019 | 1359 | 0.560 |
Why?
|
Bone Diseases, Developmental | 1 | 2017 | 130 | 0.560 |
Why?
|
Mycoses | 1 | 2019 | 376 | 0.550 |
Why?
|
Antirheumatic Agents | 6 | 2022 | 1339 | 0.540 |
Why?
|
Adult | 62 | 2023 | 214055 | 0.540 |
Why?
|
Blood Glucose | 6 | 2022 | 6256 | 0.540 |
Why?
|
Analgesics, Opioid | 9 | 2023 | 3674 | 0.540 |
Why?
|
Anti-Infective Agents, Local | 4 | 2021 | 250 | 0.540 |
Why?
|
Perioperative Period | 2 | 2018 | 256 | 0.530 |
Why?
|
Patella | 3 | 2023 | 320 | 0.530 |
Why?
|
Exercise Therapy | 2 | 2021 | 906 | 0.520 |
Why?
|
Biomedical Research | 2 | 2021 | 3309 | 0.520 |
Why?
|
Emigrants and Immigrants | 1 | 2022 | 522 | 0.520 |
Why?
|
Tissue Culture Techniques | 1 | 2016 | 290 | 0.520 |
Why?
|
Replantation | 5 | 2023 | 148 | 0.520 |
Why?
|
Chlorhexidine | 2 | 2013 | 162 | 0.520 |
Why?
|
Rheumatic Diseases | 5 | 2022 | 592 | 0.510 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2020 | 1770 | 0.510 |
Why?
|
Internship and Residency | 5 | 2023 | 5788 | 0.510 |
Why?
|
Gender Identity | 1 | 2020 | 688 | 0.510 |
Why?
|
Practice Guidelines as Topic | 5 | 2020 | 7279 | 0.500 |
Why?
|
Evidence-Based Practice | 1 | 2019 | 500 | 0.500 |
Why?
|
Patient Satisfaction | 5 | 2022 | 3396 | 0.500 |
Why?
|
Neuromuscular Agents | 1 | 2016 | 134 | 0.500 |
Why?
|
Hospital Costs | 2 | 2019 | 985 | 0.490 |
Why?
|
Venous Thrombosis | 6 | 2017 | 1239 | 0.490 |
Why?
|
Evidence-Based Medicine | 6 | 2020 | 3610 | 0.480 |
Why?
|
Alcoholics Anonymous | 1 | 2014 | 35 | 0.480 |
Why?
|
Obesity, Morbid | 2 | 2023 | 1213 | 0.470 |
Why?
|
Penicillins | 1 | 2016 | 380 | 0.460 |
Why?
|
Occupational Diseases | 1 | 2022 | 1471 | 0.450 |
Why?
|
Arthrodesis | 3 | 2020 | 189 | 0.450 |
Why?
|
Mupirocin | 1 | 2013 | 56 | 0.450 |
Why?
|
Device Removal | 1 | 2018 | 656 | 0.450 |
Why?
|
Program Evaluation | 2 | 2020 | 2488 | 0.450 |
Why?
|
Botulinum Toxins, Type A | 1 | 2016 | 213 | 0.450 |
Why?
|
Running | 1 | 2018 | 480 | 0.440 |
Why?
|
Walking | 2 | 2020 | 1180 | 0.440 |
Why?
|
Cost-Benefit Analysis | 5 | 2023 | 5391 | 0.430 |
Why?
|
Fractures, Open | 1 | 2013 | 101 | 0.430 |
Why?
|
Hospitals, General | 1 | 2017 | 749 | 0.430 |
Why?
|
Cicatrix | 1 | 2018 | 764 | 0.430 |
Why?
|
Pulmonary Embolism | 6 | 2017 | 2376 | 0.430 |
Why?
|
Intraoperative Care | 1 | 2016 | 767 | 0.430 |
Why?
|
Home Care Services | 1 | 2019 | 606 | 0.420 |
Why?
|
Philadelphia | 7 | 2017 | 266 | 0.420 |
Why?
|
Databases, Factual | 11 | 2020 | 7729 | 0.420 |
Why?
|
Language | 1 | 2021 | 1471 | 0.420 |
Why?
|
Time Factors | 19 | 2021 | 40075 | 0.410 |
Why?
|
Preoperative Care | 4 | 2016 | 2250 | 0.400 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2013 | 232 | 0.400 |
Why?
|
Surgery, Computer-Assisted | 1 | 2020 | 1018 | 0.400 |
Why?
|
Alcohol-Related Disorders | 1 | 2014 | 234 | 0.400 |
Why?
|
Blood Transfusion | 5 | 2018 | 1301 | 0.380 |
Why?
|
Acetabulum | 6 | 2023 | 525 | 0.380 |
Why?
|
Ambulatory Surgical Procedures | 3 | 2022 | 454 | 0.380 |
Why?
|
Community Mental Health Services | 1 | 2014 | 386 | 0.370 |
Why?
|
Mental Health Services | 1 | 2022 | 1643 | 0.370 |
Why?
|
Incidence | 19 | 2023 | 20947 | 0.360 |
Why?
|
Collagen | 1 | 2018 | 2689 | 0.350 |
Why?
|
Obesity | 8 | 2023 | 12745 | 0.350 |
Why?
|
Femur Head | 5 | 2018 | 301 | 0.340 |
Why?
|
Venous Thromboembolism | 7 | 2021 | 1671 | 0.340 |
Why?
|
Gout | 1 | 2016 | 573 | 0.340 |
Why?
|
Mass Screening | 3 | 2013 | 5255 | 0.340 |
Why?
|
Povidone-Iodine | 3 | 2021 | 59 | 0.330 |
Why?
|
Knee | 5 | 2024 | 274 | 0.330 |
Why?
|
Pain Measurement | 8 | 2020 | 3420 | 0.330 |
Why?
|
Bupivacaine | 2 | 2022 | 411 | 0.330 |
Why?
|
Risk Assessment | 6 | 2021 | 23338 | 0.330 |
Why?
|
End Stage Liver Disease | 2 | 2023 | 314 | 0.320 |
Why?
|
Patient Readmission | 5 | 2023 | 3114 | 0.320 |
Why?
|
Aspirin | 6 | 2019 | 3282 | 0.320 |
Why?
|
Patient Discharge | 7 | 2022 | 3313 | 0.320 |
Why?
|
Spine | 3 | 2022 | 1144 | 0.310 |
Why?
|
Physical Therapy Modalities | 1 | 2012 | 550 | 0.310 |
Why?
|
International Classification of Diseases | 3 | 2023 | 867 | 0.310 |
Why?
|
Cost of Illness | 1 | 2017 | 1859 | 0.310 |
Why?
|
Knee Injuries | 2 | 2023 | 490 | 0.310 |
Why?
|
Telemedicine | 2 | 2022 | 2872 | 0.310 |
Why?
|
Hip Dislocation, Congenital | 2 | 2020 | 225 | 0.310 |
Why?
|
Ambulatory Care | 1 | 2019 | 2708 | 0.310 |
Why?
|
Humerus | 2 | 2020 | 266 | 0.310 |
Why?
|
Drug Hypersensitivity | 1 | 2016 | 884 | 0.300 |
Why?
|
Odds Ratio | 7 | 2020 | 9849 | 0.300 |
Why?
|
Hospital Mortality | 5 | 2016 | 5317 | 0.300 |
Why?
|
Lupus Erythematosus, Systemic | 5 | 2022 | 2104 | 0.290 |
Why?
|
Spinal Diseases | 3 | 2020 | 538 | 0.290 |
Why?
|
Comorbidity | 8 | 2021 | 10388 | 0.290 |
Why?
|
Students, Medical | 1 | 2020 | 1862 | 0.290 |
Why?
|
Sexual Behavior | 1 | 2016 | 2057 | 0.290 |
Why?
|
Peripheral Vascular Diseases | 2 | 2023 | 550 | 0.290 |
Why?
|
Drug Administration Schedule | 4 | 2019 | 4933 | 0.280 |
Why?
|
Bone and Bones | 1 | 2017 | 2575 | 0.280 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3022 | 0.280 |
Why?
|
Corrosion | 4 | 2018 | 29 | 0.270 |
Why?
|
Equipment Contamination | 2 | 2019 | 185 | 0.270 |
Why?
|
Ceramics | 2 | 2017 | 105 | 0.270 |
Why?
|
Tobramycin | 2 | 2017 | 69 | 0.270 |
Why?
|
Clinical Competence | 2 | 2020 | 4687 | 0.260 |
Why?
|
Cartilage, Articular | 2 | 2013 | 1095 | 0.260 |
Why?
|
Artificial Intelligence | 4 | 2023 | 2214 | 0.260 |
Why?
|
Perioperative Care | 3 | 2017 | 1002 | 0.260 |
Why?
|
Anesthetics, Local | 2 | 2022 | 985 | 0.260 |
Why?
|
Disinfection | 3 | 2019 | 191 | 0.250 |
Why?
|
Case-Control Studies | 7 | 2023 | 21746 | 0.250 |
Why?
|
Treatment Failure | 5 | 2017 | 2618 | 0.250 |
Why?
|
Quality Improvement | 4 | 2020 | 3749 | 0.240 |
Why?
|
Polyethylene | 4 | 2017 | 184 | 0.240 |
Why?
|
Methylmethacrylate | 1 | 2023 | 44 | 0.240 |
Why?
|
Second-Look Surgery | 1 | 2023 | 29 | 0.230 |
Why?
|
Inpatients | 4 | 2021 | 2518 | 0.230 |
Why?
|
Registries | 8 | 2023 | 8089 | 0.230 |
Why?
|
Awards and Prizes | 2 | 2019 | 375 | 0.220 |
Why?
|
Ventilation | 1 | 2023 | 127 | 0.220 |
Why?
|
Pandemics | 7 | 2022 | 8388 | 0.220 |
Why?
|
Adrenal Cortex Hormones | 3 | 2021 | 1855 | 0.220 |
Why?
|
Fibrosis | 2 | 2020 | 2029 | 0.210 |
Why?
|
Logistic Models | 7 | 2019 | 13408 | 0.210 |
Why?
|
C-Reactive Protein | 5 | 2022 | 3778 | 0.210 |
Why?
|
Societies, Medical | 5 | 2021 | 3743 | 0.200 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2016 | 2208 | 0.200 |
Why?
|
Practice Management | 1 | 2022 | 37 | 0.200 |
Why?
|
Lower Extremity | 5 | 2024 | 1158 | 0.200 |
Why?
|
Hip | 2 | 2020 | 257 | 0.200 |
Why?
|
Developing Countries | 1 | 2014 | 2815 | 0.200 |
Why?
|
Anti-Infective Agents | 3 | 2020 | 972 | 0.200 |
Why?
|
Anticoagulants | 5 | 2019 | 4599 | 0.200 |
Why?
|
Fractures, Stress | 1 | 2023 | 187 | 0.200 |
Why?
|
Postoperative Care | 2 | 2020 | 1486 | 0.200 |
Why?
|
Cobalt | 2 | 2018 | 158 | 0.190 |
Why?
|
Focus Groups | 2 | 2017 | 1321 | 0.190 |
Why?
|
Hexosaminidases | 1 | 2020 | 54 | 0.190 |
Why?
|
Penile Implantation | 1 | 2020 | 16 | 0.190 |
Why?
|
Ceftazidime | 1 | 2020 | 69 | 0.190 |
Why?
|
Chromium | 2 | 2018 | 123 | 0.190 |
Why?
|
Antifibrinolytic Agents | 2 | 2021 | 254 | 0.190 |
Why?
|
Prevalence | 6 | 2023 | 15226 | 0.190 |
Why?
|
Inappropriate Prescribing | 2 | 2022 | 202 | 0.190 |
Why?
|
Penile Prosthesis | 1 | 2020 | 38 | 0.190 |
Why?
|
Morbidity | 3 | 2022 | 1769 | 0.180 |
Why?
|
Bipolar Disorder | 1 | 2017 | 5027 | 0.180 |
Why?
|
Hospitals | 6 | 2022 | 3952 | 0.180 |
Why?
|
Hip Dislocation | 1 | 2023 | 244 | 0.180 |
Why?
|
Cementation | 2 | 2023 | 91 | 0.180 |
Why?
|
Cohort Studies | 9 | 2023 | 40561 | 0.180 |
Why?
|
Glucocorticoids | 5 | 2022 | 2107 | 0.180 |
Why?
|
Analgesics | 2 | 2019 | 1040 | 0.180 |
Why?
|
Body Mass Index | 5 | 2021 | 12720 | 0.180 |
Why?
|
Industry | 1 | 2022 | 365 | 0.170 |
Why?
|
Carboxylic Ester Hydrolases | 2 | 2018 | 98 | 0.170 |
Why?
|
Penis | 1 | 2020 | 216 | 0.170 |
Why?
|
International Normalized Ratio | 1 | 2021 | 367 | 0.170 |
Why?
|
Compression Bandages | 1 | 2019 | 15 | 0.170 |
Why?
|
Surface-Active Agents | 1 | 2020 | 159 | 0.170 |
Why?
|
Bone Malalignment | 1 | 2019 | 38 | 0.170 |
Why?
|
Spouses | 1 | 2021 | 286 | 0.170 |
Why?
|
Diabetes Mellitus | 4 | 2022 | 5751 | 0.170 |
Why?
|
Consensus | 4 | 2024 | 2959 | 0.170 |
Why?
|
Schizophrenia | 1 | 2017 | 6882 | 0.170 |
Why?
|
Antibiotics, Antitubercular | 1 | 2019 | 104 | 0.170 |
Why?
|
Macrophage Activation | 1 | 2022 | 558 | 0.170 |
Why?
|
Medial Collateral Ligament, Knee | 1 | 2018 | 25 | 0.170 |
Why?
|
Pamphlets | 1 | 2019 | 75 | 0.170 |
Why?
|
Quorum Sensing | 1 | 2020 | 131 | 0.160 |
Why?
|
Ciprofloxacin | 1 | 2020 | 315 | 0.160 |
Why?
|
DNA Damage | 1 | 2008 | 2432 | 0.160 |
Why?
|
Thromboembolism | 2 | 2017 | 986 | 0.160 |
Why?
|
Powders | 1 | 2018 | 80 | 0.160 |
Why?
|
Patient Care Team | 2 | 2020 | 2531 | 0.160 |
Why?
|
Critical Pathways | 1 | 2022 | 476 | 0.160 |
Why?
|
Pennsylvania | 2 | 2017 | 613 | 0.160 |
Why?
|
Canada | 2 | 2023 | 2065 | 0.160 |
Why?
|
Costs and Cost Analysis | 2 | 2021 | 1681 | 0.160 |
Why?
|
Wrist | 1 | 2020 | 224 | 0.160 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3133 | 0.160 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3240 | 0.160 |
Why?
|
Practice Management, Medical | 1 | 2019 | 196 | 0.150 |
Why?
|
Ultrasonic Therapy | 1 | 2020 | 235 | 0.150 |
Why?
|
Drug Resistance, Microbial | 1 | 2021 | 862 | 0.150 |
Why?
|
Fever | 2 | 2016 | 1616 | 0.150 |
Why?
|
Osteogenesis Imperfecta | 1 | 2018 | 83 | 0.150 |
Why?
|
Oxidative Stress | 1 | 2008 | 3086 | 0.150 |
Why?
|
Rupture | 1 | 2019 | 433 | 0.150 |
Why?
|
Cross-Over Studies | 2 | 2020 | 2029 | 0.150 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2018 | 89 | 0.150 |
Why?
|
Diet, Reducing | 1 | 2020 | 462 | 0.150 |
Why?
|
Activities of Daily Living | 3 | 2022 | 2418 | 0.150 |
Why?
|
Kidney Failure, Chronic | 2 | 2023 | 2538 | 0.150 |
Why?
|
Conflict of Interest | 1 | 2022 | 544 | 0.150 |
Why?
|
Specialties, Surgical | 1 | 2022 | 391 | 0.150 |
Why?
|
Cold Temperature | 1 | 2020 | 772 | 0.140 |
Why?
|
Fibrinolytic Agents | 2 | 2017 | 2158 | 0.140 |
Why?
|
Sex Factors | 3 | 2020 | 10397 | 0.140 |
Why?
|
Lighting | 1 | 2019 | 231 | 0.140 |
Why?
|
Porosity | 2 | 2017 | 362 | 0.140 |
Why?
|
Pain | 2 | 2022 | 4986 | 0.140 |
Why?
|
Ankle | 1 | 2020 | 327 | 0.140 |
Why?
|
Epidemics | 1 | 2022 | 523 | 0.140 |
Why?
|
Achilles Tendon | 1 | 2019 | 157 | 0.140 |
Why?
|
Erectile Dysfunction | 1 | 2020 | 461 | 0.140 |
Why?
|
Subacute Care | 1 | 2019 | 168 | 0.140 |
Why?
|
Outpatients | 2 | 2021 | 1486 | 0.140 |
Why?
|
Young Adult | 11 | 2021 | 56430 | 0.140 |
Why?
|
Immunity, Humoral | 1 | 2020 | 598 | 0.140 |
Why?
|
Organizational Culture | 1 | 2020 | 510 | 0.140 |
Why?
|
Health Status Indicators | 1 | 2021 | 969 | 0.140 |
Why?
|
Administration, Intranasal | 2 | 2017 | 446 | 0.140 |
Why?
|
Career Choice | 2 | 2022 | 744 | 0.130 |
Why?
|
Blood Grouping and Crossmatching | 1 | 2016 | 107 | 0.130 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2020 | 692 | 0.130 |
Why?
|
Disability Evaluation | 2 | 2021 | 1827 | 0.130 |
Why?
|
North Carolina | 1 | 2016 | 315 | 0.130 |
Why?
|
Research Personnel | 1 | 2020 | 573 | 0.130 |
Why?
|
Adolescent | 10 | 2021 | 85781 | 0.130 |
Why?
|
Osseointegration | 1 | 2017 | 276 | 0.130 |
Why?
|
Urology | 1 | 2020 | 399 | 0.130 |
Why?
|
Fluoroscopy | 1 | 2020 | 924 | 0.130 |
Why?
|
Joint Instability | 2 | 2020 | 792 | 0.130 |
Why?
|
Blood Loss, Surgical | 2 | 2016 | 662 | 0.130 |
Why?
|
Severity of Illness Index | 5 | 2023 | 15540 | 0.130 |
Why?
|
Predictive Value of Tests | 4 | 2018 | 15076 | 0.130 |
Why?
|
Tendon Injuries | 1 | 2019 | 313 | 0.130 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.130 |
Why?
|
Interleukin-6 | 2 | 2023 | 3200 | 0.130 |
Why?
|
Multivariate Analysis | 3 | 2018 | 12245 | 0.130 |
Why?
|
Injections, Intramuscular | 1 | 2016 | 552 | 0.130 |
Why?
|
Markov Chains | 1 | 2018 | 969 | 0.130 |
Why?
|
Chemoprevention | 2 | 2017 | 319 | 0.130 |
Why?
|
Single-Blind Method | 1 | 2019 | 1590 | 0.130 |
Why?
|
Sex Distribution | 1 | 2020 | 2297 | 0.130 |
Why?
|
Quality of Life | 5 | 2023 | 12804 | 0.130 |
Why?
|
Causality | 1 | 2021 | 1275 | 0.130 |
Why?
|
Efficiency, Organizational | 1 | 2019 | 695 | 0.130 |
Why?
|
Kidney Diseases | 2 | 2016 | 2149 | 0.120 |
Why?
|
Antifungal Agents | 1 | 2019 | 730 | 0.120 |
Why?
|
Blister | 1 | 2015 | 86 | 0.120 |
Why?
|
Urinary Retention | 1 | 2015 | 111 | 0.120 |
Why?
|
Saint Vincent and the Grenadines | 1 | 2014 | 3 | 0.120 |
Why?
|
New York | 1 | 2017 | 886 | 0.120 |
Why?
|
Edema | 1 | 2019 | 789 | 0.120 |
Why?
|
Urinary Catheterization | 1 | 2015 | 202 | 0.120 |
Why?
|
Hemoglobinopathies | 1 | 2015 | 96 | 0.120 |
Why?
|
Electrocoagulation | 1 | 2015 | 158 | 0.120 |
Why?
|
Congresses as Topic | 1 | 2019 | 764 | 0.120 |
Why?
|
Ownership | 1 | 2017 | 332 | 0.120 |
Why?
|
Bacterial Toxins | 1 | 2020 | 931 | 0.120 |
Why?
|
Gastric Bypass | 1 | 2023 | 812 | 0.120 |
Why?
|
Weight-Bearing | 1 | 2016 | 515 | 0.120 |
Why?
|
Lymphocytes | 1 | 2022 | 2617 | 0.120 |
Why?
|
Recurrence | 3 | 2016 | 8340 | 0.120 |
Why?
|
Tourniquets | 1 | 2015 | 110 | 0.120 |
Why?
|
Interviews as Topic | 2 | 2019 | 2539 | 0.120 |
Why?
|
Leadership | 2 | 2021 | 1357 | 0.120 |
Why?
|
Medical Records Systems, Computerized | 1 | 2020 | 1205 | 0.120 |
Why?
|
Propensity Score | 2 | 2019 | 1781 | 0.120 |
Why?
|
Bacterial Translocation | 1 | 2014 | 73 | 0.120 |
Why?
|
False Positive Reactions | 1 | 2016 | 981 | 0.120 |
Why?
|
Warfarin | 3 | 2019 | 1496 | 0.120 |
Why?
|
Liver Diseases | 1 | 2022 | 1253 | 0.120 |
Why?
|
Interprofessional Relations | 1 | 2020 | 1011 | 0.120 |
Why?
|
Organ Transplantation | 2 | 2014 | 1139 | 0.110 |
Why?
|
Cost Savings | 2 | 2023 | 926 | 0.110 |
Why?
|
Photochemotherapy | 1 | 2020 | 807 | 0.110 |
Why?
|
Stroke | 1 | 2016 | 9981 | 0.110 |
Why?
|
Weight Loss | 2 | 2023 | 2622 | 0.110 |
Why?
|
Baths | 1 | 2013 | 54 | 0.110 |
Why?
|
Florida | 1 | 2014 | 435 | 0.110 |
Why?
|
Quality Indicators, Health Care | 1 | 2023 | 1831 | 0.110 |
Why?
|
International Cooperation | 1 | 2020 | 1420 | 0.110 |
Why?
|
Prognosis | 4 | 2022 | 29063 | 0.110 |
Why?
|
Tensile Strength | 1 | 2014 | 335 | 0.110 |
Why?
|
Cross-Sectional Studies | 5 | 2022 | 25043 | 0.110 |
Why?
|
Gentamicins | 1 | 2014 | 255 | 0.110 |
Why?
|
Age Factors | 3 | 2020 | 18370 | 0.110 |
Why?
|
Titanium | 3 | 2023 | 494 | 0.110 |
Why?
|
Catheters | 1 | 2016 | 425 | 0.110 |
Why?
|
Hepatitis C | 1 | 2023 | 1591 | 0.110 |
Why?
|
Vertebral Artery | 1 | 2013 | 192 | 0.110 |
Why?
|
Coated Materials, Biocompatible | 1 | 2014 | 319 | 0.100 |
Why?
|
Anterior Cruciate Ligament | 1 | 2015 | 415 | 0.100 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2020 | 941 | 0.100 |
Why?
|
Cervical Vertebrae | 2 | 2021 | 975 | 0.100 |
Why?
|
Stress, Mechanical | 2 | 2015 | 1686 | 0.100 |
Why?
|
Quality-Adjusted Life Years | 1 | 2018 | 1683 | 0.100 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 503 | 0.100 |
Why?
|
Mutagenesis | 1 | 2016 | 1266 | 0.100 |
Why?
|
Mental Health | 2 | 2024 | 3019 | 0.100 |
Why?
|
Diffusion | 1 | 2014 | 833 | 0.100 |
Why?
|
Spondylolisthesis | 1 | 2013 | 163 | 0.100 |
Why?
|
Physicians | 2 | 2022 | 4567 | 0.100 |
Why?
|
Mesenchymal Stem Cells | 2 | 2020 | 1632 | 0.100 |
Why?
|
Hepatitis C, Chronic | 1 | 2020 | 1031 | 0.100 |
Why?
|
Sensitivity and Specificity | 5 | 2018 | 14722 | 0.100 |
Why?
|
Hemorrhage | 2 | 2021 | 3461 | 0.100 |
Why?
|
Homozygote | 1 | 2016 | 1785 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 1477 | 0.100 |
Why?
|
Statistics, Nonparametric | 1 | 2017 | 2886 | 0.100 |
Why?
|
Vaccines | 1 | 2020 | 822 | 0.100 |
Why?
|
Forecasting | 2 | 2017 | 2951 | 0.100 |
Why?
|
Spinal Fusion | 1 | 2020 | 1241 | 0.100 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39050 | 0.100 |
Why?
|
Phenylephrine | 1 | 2011 | 301 | 0.090 |
Why?
|
Swine | 3 | 2023 | 5917 | 0.090 |
Why?
|
Genetic Engineering | 1 | 2016 | 951 | 0.090 |
Why?
|
Angiography, Digital Subtraction | 1 | 2011 | 341 | 0.090 |
Why?
|
Health Resources | 1 | 2016 | 911 | 0.090 |
Why?
|
Vascular System Injuries | 1 | 2013 | 250 | 0.090 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3508 | 0.090 |
Why?
|
Bone Plates | 1 | 2013 | 468 | 0.090 |
Why?
|
Spinal Injuries | 1 | 2013 | 301 | 0.090 |
Why?
|
Viscosity | 2 | 2022 | 328 | 0.090 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2759 | 0.090 |
Why?
|
Neutrophils | 1 | 2022 | 3719 | 0.090 |
Why?
|
Sweden | 2 | 2023 | 1345 | 0.090 |
Why?
|
Periodicals as Topic | 1 | 2020 | 1432 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2022 | 3528 | 0.090 |
Why?
|
Nerve Block | 1 | 2016 | 644 | 0.090 |
Why?
|
Pilot Projects | 3 | 2023 | 8324 | 0.090 |
Why?
|
Heterozygote | 1 | 2016 | 2804 | 0.090 |
Why?
|
Occupational Exposure | 1 | 2020 | 1796 | 0.090 |
Why?
|
Sutures | 2 | 2024 | 299 | 0.080 |
Why?
|
Accreditation | 2 | 2023 | 450 | 0.080 |
Why?
|
Patient Admission | 1 | 2017 | 1380 | 0.080 |
Why?
|
Peroxynitrous Acid | 1 | 2008 | 41 | 0.080 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2022 | 434 | 0.080 |
Why?
|
Nitroso Compounds | 1 | 2008 | 72 | 0.080 |
Why?
|
Qualitative Research | 1 | 2017 | 2682 | 0.080 |
Why?
|
Acetonitriles | 1 | 2008 | 53 | 0.080 |
Why?
|
Erythrocyte Transfusion | 1 | 2013 | 565 | 0.080 |
Why?
|
Leukocyte Count | 3 | 2018 | 1588 | 0.080 |
Why?
|
Fractures, Bone | 2 | 2017 | 1947 | 0.080 |
Why?
|
Bandages | 2 | 2024 | 266 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3047 | 0.080 |
Why?
|
Nanoparticles | 1 | 2020 | 1905 | 0.080 |
Why?
|
Glomerular Filtration Rate | 1 | 2016 | 2170 | 0.080 |
Why?
|
Biological Products | 1 | 2017 | 860 | 0.080 |
Why?
|
Heart Valve Diseases | 1 | 2016 | 1073 | 0.080 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2014 | 1121 | 0.080 |
Why?
|
X-Rays | 1 | 2008 | 301 | 0.080 |
Why?
|
Vasoconstrictor Agents | 1 | 2011 | 642 | 0.080 |
Why?
|
Risk | 2 | 2017 | 9687 | 0.080 |
Why?
|
Animals | 11 | 2023 | 168757 | 0.080 |
Why?
|
Chondrocytes | 2 | 2013 | 804 | 0.080 |
Why?
|
Public Health | 1 | 2021 | 2603 | 0.080 |
Why?
|
Program Development | 1 | 2014 | 1316 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8642 | 0.070 |
Why?
|
Catheter Ablation | 1 | 2020 | 2758 | 0.070 |
Why?
|
Health Care Costs | 2 | 2023 | 3209 | 0.070 |
Why?
|
Intention to Treat Analysis | 2 | 2019 | 426 | 0.070 |
Why?
|
Blood Sedimentation | 2 | 2018 | 231 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3508 | 0.070 |
Why?
|
Internet | 1 | 2019 | 3064 | 0.070 |
Why?
|
Reproducibility of Results | 3 | 2021 | 19905 | 0.070 |
Why?
|
Calibration | 1 | 2008 | 816 | 0.070 |
Why?
|
Arrhythmias, Cardiac | 1 | 2016 | 2268 | 0.070 |
Why?
|
Bacteria | 1 | 2016 | 2114 | 0.070 |
Why?
|
Spondylitis, Ankylosing | 2 | 2017 | 156 | 0.070 |
Why?
|
Research Design | 1 | 2021 | 5987 | 0.070 |
Why?
|
Morpholines | 1 | 2008 | 571 | 0.070 |
Why?
|
Double-Blind Method | 2 | 2016 | 12026 | 0.070 |
Why?
|
Wound Healing | 1 | 2016 | 2785 | 0.060 |
Why?
|
Diagnostic Tests, Routine | 2 | 2023 | 783 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2018 | 9959 | 0.060 |
Why?
|
Peripheral Nerves | 2 | 2020 | 466 | 0.060 |
Why?
|
Inflammation | 2 | 2022 | 10638 | 0.060 |
Why?
|
Bacterial Infections | 1 | 2013 | 1401 | 0.060 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6171 | 0.060 |
Why?
|
Arthritis, Psoriatic | 2 | 2017 | 215 | 0.060 |
Why?
|
DNA Repair | 2 | 2016 | 2046 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4445 | 0.060 |
Why?
|
Regeneration | 1 | 2013 | 1485 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4149 | 0.060 |
Why?
|
Critical Care | 1 | 2017 | 2647 | 0.060 |
Why?
|
Exercise | 1 | 2020 | 5615 | 0.060 |
Why?
|
Endoscopy | 1 | 2014 | 1785 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5137 | 0.060 |
Why?
|
Amikacin | 1 | 2023 | 48 | 0.060 |
Why?
|
ROC Curve | 2 | 2022 | 3527 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2016 | 3068 | 0.060 |
Why?
|
Neoplasms | 2 | 2023 | 21683 | 0.060 |
Why?
|
Chronic Disease | 2 | 2022 | 9146 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2019 | 4468 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9274 | 0.050 |
Why?
|
Microbubbles | 1 | 2023 | 128 | 0.050 |
Why?
|
Europe | 2 | 2020 | 3339 | 0.050 |
Why?
|
Prostheses and Implants | 1 | 2009 | 1387 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2014 | 3297 | 0.050 |
Why?
|
Delphi Technique | 1 | 2024 | 778 | 0.050 |
Why?
|
Hospitals, Public | 1 | 2022 | 207 | 0.050 |
Why?
|
Pyrroles | 2 | 2017 | 1146 | 0.050 |
Why?
|
Drug Resistance, Bacterial | 2 | 2020 | 1035 | 0.050 |
Why?
|
Intraoperative Complications | 2 | 2018 | 1198 | 0.040 |
Why?
|
Smoking | 1 | 2017 | 8987 | 0.040 |
Why?
|
Fees and Charges | 1 | 2021 | 195 | 0.040 |
Why?
|
Education, Medical, Graduate | 2 | 2023 | 2291 | 0.040 |
Why?
|
Nitric Oxide | 1 | 2008 | 2132 | 0.040 |
Why?
|
Choline | 1 | 2021 | 493 | 0.040 |
Why?
|
Cell Nucleus | 1 | 2008 | 2969 | 0.040 |
Why?
|
Professional Practice | 1 | 2022 | 326 | 0.040 |
Why?
|
Sleep | 1 | 2015 | 4623 | 0.040 |
Why?
|
Survival Analysis | 1 | 2012 | 10252 | 0.040 |
Why?
|
Creatine | 1 | 2021 | 421 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2014 | 3923 | 0.040 |
Why?
|
Synovial Membrane | 1 | 2022 | 507 | 0.040 |
Why?
|
Heart Failure | 1 | 2023 | 10900 | 0.040 |
Why?
|
Aspartic Acid | 1 | 2021 | 576 | 0.040 |
Why?
|
Culture Media, Conditioned | 1 | 2020 | 537 | 0.040 |
Why?
|
Piperidines | 2 | 2017 | 1602 | 0.040 |
Why?
|
Pelvis | 1 | 2023 | 730 | 0.040 |
Why?
|
Policy | 1 | 2022 | 508 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2022 | 20129 | 0.040 |
Why?
|
Cultural Diversity | 1 | 2022 | 359 | 0.040 |
Why?
|
Algorithms | 2 | 2021 | 13881 | 0.040 |
Why?
|
Gastrectomy | 1 | 2023 | 663 | 0.040 |
Why?
|
Bibliometrics | 1 | 2022 | 339 | 0.040 |
Why?
|
Nuclear Medicine | 1 | 2021 | 233 | 0.040 |
Why?
|
Communication | 2 | 2023 | 3749 | 0.040 |
Why?
|
Alloys | 1 | 2018 | 122 | 0.040 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2017 | 164 | 0.040 |
Why?
|
Frozen Sections | 1 | 2018 | 155 | 0.040 |
Why?
|
Virginia | 1 | 2017 | 121 | 0.040 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2019 | 339 | 0.040 |
Why?
|
Models, Animal | 1 | 2023 | 2171 | 0.040 |
Why?
|
Sterilization | 1 | 2017 | 133 | 0.040 |
Why?
|
Creatinine | 1 | 2022 | 1919 | 0.040 |
Why?
|
Mechanical Phenomena | 1 | 2018 | 140 | 0.040 |
Why?
|
Hand | 1 | 2022 | 884 | 0.040 |
Why?
|
Intermittent Pneumatic Compression Devices | 1 | 2016 | 25 | 0.040 |
Why?
|
Posture | 1 | 2021 | 958 | 0.040 |
Why?
|
Spondylarthritis | 1 | 2017 | 62 | 0.030 |
Why?
|
Reagent Strips | 1 | 2016 | 39 | 0.030 |
Why?
|
Quadriceps Muscle | 1 | 2017 | 144 | 0.030 |
Why?
|
Templates, Genetic | 1 | 2016 | 211 | 0.030 |
Why?
|
DNA Cleavage | 1 | 2016 | 58 | 0.030 |
Why?
|
Sequence Homology | 1 | 2016 | 203 | 0.030 |
Why?
|
Presenilins | 1 | 2016 | 54 | 0.030 |
Why?
|
Ligaments, Articular | 1 | 2018 | 298 | 0.030 |
Why?
|
2-Propanol | 1 | 2015 | 28 | 0.030 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2018 | 426 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2023 | 1741 | 0.030 |
Why?
|
Bacterial Typing Techniques | 1 | 2016 | 256 | 0.030 |
Why?
|
Hepacivirus | 1 | 2023 | 1379 | 0.030 |
Why?
|
Suppuration | 1 | 2015 | 56 | 0.030 |
Why?
|
Trust | 1 | 2020 | 505 | 0.030 |
Why?
|
Environment, Controlled | 1 | 2015 | 46 | 0.030 |
Why?
|
Schools, Medical | 1 | 2022 | 880 | 0.030 |
Why?
|
Politics | 1 | 2022 | 791 | 0.030 |
Why?
|
Hospitalization | 3 | 2023 | 10262 | 0.030 |
Why?
|
Pyrimidines | 2 | 2017 | 2942 | 0.030 |
Why?
|
Unnecessary Procedures | 1 | 2019 | 432 | 0.030 |
Why?
|
Hematocrit | 1 | 2016 | 636 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 20822 | 0.030 |
Why?
|
DNA | 1 | 2008 | 7301 | 0.030 |
Why?
|
Hospital Charges | 1 | 2016 | 362 | 0.030 |
Why?
|
Surface Properties | 1 | 2017 | 1184 | 0.030 |
Why?
|
Episode of Care | 1 | 2015 | 126 | 0.030 |
Why?
|
Lumbar Vertebrae | 2 | 2013 | 1848 | 0.030 |
Why?
|
Oxycodone | 1 | 2016 | 153 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2022 | 2453 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2022 | 4751 | 0.030 |
Why?
|
Nasal Mucosa | 1 | 2017 | 373 | 0.030 |
Why?
|
Hospitals, University | 1 | 2016 | 571 | 0.030 |
Why?
|
Water | 1 | 2020 | 1395 | 0.030 |
Why?
|
Bacteriological Techniques | 1 | 2015 | 277 | 0.030 |
Why?
|
Area Under Curve | 1 | 2018 | 1654 | 0.030 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5319 | 0.030 |
Why?
|
Carrier State | 1 | 2017 | 518 | 0.030 |
Why?
|
Hematoma, Epidural, Spinal | 1 | 2013 | 36 | 0.030 |
Why?
|
Genes, Dominant | 1 | 2016 | 880 | 0.030 |
Why?
|
Drainage | 1 | 2019 | 1142 | 0.030 |
Why?
|
Likelihood Functions | 1 | 2016 | 1005 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2023 | 2282 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1863 | 0.030 |
Why?
|
Skin | 2 | 2017 | 4364 | 0.030 |
Why?
|
Ethanol | 1 | 2019 | 1342 | 0.030 |
Why?
|
Laminectomy | 1 | 2013 | 234 | 0.030 |
Why?
|
Office Visits | 1 | 2017 | 598 | 0.030 |
Why?
|
Psychometrics | 1 | 2021 | 3002 | 0.030 |
Why?
|
Drug Prescriptions | 1 | 2021 | 1637 | 0.030 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2014 | 320 | 0.030 |
Why?
|
Bioreactors | 1 | 2013 | 236 | 0.030 |
Why?
|
Materials Testing | 1 | 2015 | 867 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2016 | 1801 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2187 | 0.030 |
Why?
|
Diskectomy | 1 | 2013 | 206 | 0.030 |
Why?
|
Morphine | 1 | 2016 | 657 | 0.030 |
Why?
|
Fear | 1 | 2020 | 1440 | 0.020 |
Why?
|
Mutation | 1 | 2016 | 29786 | 0.020 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2016 | 594 | 0.020 |
Why?
|
Metals | 1 | 2016 | 719 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 2183 | 0.020 |
Why?
|
Analgesia | 1 | 2016 | 461 | 0.020 |
Why?
|
Acute Disease | 1 | 2022 | 7149 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 3760 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1462 | 0.020 |
Why?
|
Workload | 1 | 2017 | 850 | 0.020 |
Why?
|
Platelet-Rich Plasma | 1 | 2013 | 177 | 0.020 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2016 | 1121 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 2011 | 862 | 0.020 |
Why?
|
Rats | 2 | 2020 | 24260 | 0.020 |
Why?
|
Acetaminophen | 1 | 2014 | 545 | 0.020 |
Why?
|
Hemoglobins | 1 | 2016 | 1534 | 0.020 |
Why?
|
Kidney Transplantation | 2 | 2015 | 4251 | 0.020 |
Why?
|
Reimbursement, Incentive | 1 | 2015 | 540 | 0.020 |
Why?
|
Age of Onset | 1 | 2016 | 3271 | 0.020 |
Why?
|
Crohn Disease | 1 | 2022 | 2303 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6489 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5952 | 0.020 |
Why?
|
Decompression, Surgical | 1 | 2013 | 594 | 0.020 |
Why?
|
Pulmonary Circulation | 1 | 2011 | 739 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2020 | 3279 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2013 | 2124 | 0.020 |
Why?
|
Insulin | 1 | 2022 | 6580 | 0.020 |
Why?
|
Decision Making | 1 | 2021 | 3887 | 0.020 |
Why?
|
Fibroblast Growth Factors | 1 | 2013 | 879 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2015 | 1736 | 0.020 |
Why?
|
Device Approval | 1 | 2009 | 163 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2703 | 0.020 |
Why?
|
Disease Management | 1 | 2017 | 2459 | 0.020 |
Why?
|
Tissue Scaffolds | 1 | 2013 | 956 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2015 | 1786 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2022 | 19229 | 0.020 |
Why?
|
Oxygen | 1 | 2017 | 4189 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12959 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2013 | 2007 | 0.020 |
Why?
|
Disease Progression | 1 | 2022 | 13284 | 0.020 |
Why?
|
Alleles | 1 | 2016 | 6933 | 0.020 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2015 | 1209 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2016 | 1736 | 0.020 |
Why?
|
Base Sequence | 1 | 2016 | 12797 | 0.020 |
Why?
|
Sulfonamides | 1 | 2014 | 1938 | 0.020 |
Why?
|
Biopsy | 1 | 2016 | 6756 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10943 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2023 | 18029 | 0.020 |
Why?
|
Pyrazoles | 1 | 2014 | 1972 | 0.010 |
Why?
|
Liver Transplantation | 1 | 2014 | 2119 | 0.010 |
Why?
|
Aorta | 1 | 2011 | 2061 | 0.010 |
Why?
|
Mice | 2 | 2023 | 81183 | 0.010 |
Why?
|
Tissue Engineering | 1 | 2013 | 1880 | 0.010 |
Why?
|
Software | 1 | 2017 | 4443 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2015 | 3229 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2016 | 3507 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5535 | 0.010 |
Why?
|
United States Food and Drug Administration | 1 | 2009 | 1584 | 0.010 |
Why?
|
Child | 2 | 2019 | 77709 | 0.010 |
Why?
|
Cognition | 1 | 2015 | 6770 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2017 | 7659 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 41006 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11483 | 0.010 |
Why?
|
Blood Pressure | 1 | 2011 | 8554 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2016 | 8037 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 35421 | 0.000 |
Why?
|